- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 9L9: (2S)-2-[[4-[[2,4-bis(azanyl)-6-oxidanylidene-1H-pyrimidin-5-yl]carbamoylamino]phenyl]carbonylamino]pentanedioic acid(Non-covalent)
- 8 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.2: 5 residues within 4Å:- Chain A: R.167, R.199
- Chain B: D.182, H.185
- Ligands: NAD.6
7 PLIP interactions:4 interactions with chain A, 3 interactions with chain B- Water bridges: A:R.167, A:R.167, B:D.182
- Salt bridges: A:R.167, A:R.199, B:H.185
- Hydrogen bonds: B:D.182
PO4.3: 5 residues within 4Å:- Chain A: L.133, D.134, Q.135, H.185, E.186
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:D.134, A:E.186
- Salt bridges: A:H.185
PO4.4: 5 residues within 4Å:- Chain A: L.139, W.144, W.147, R.187, P.188
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:W.147, A:P.188
PO4.5: 3 residues within 4Å:- Chain A: I.126, R.130
- Chain B: V.125
2 PLIP interactions:1 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:N.112
- Salt bridges: A:R.130
PO4.8: 5 residues within 4Å:- Chain A: D.182, H.185
- Chain B: R.167, R.199
- Ligands: NAD.12
7 PLIP interactions:4 interactions with chain A, 3 interactions with chain B- Hydrogen bonds: A:D.182
- Water bridges: A:D.182, A:H.185, B:R.167
- Salt bridges: A:H.185, B:R.167, B:R.199
PO4.9: 5 residues within 4Å:- Chain B: L.133, D.134, Q.135, H.185, E.186
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:D.134, B:E.186
- Salt bridges: B:H.185
PO4.10: 5 residues within 4Å:- Chain B: L.139, W.144, W.147, R.187, P.188
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:W.147, B:P.188
PO4.11: 3 residues within 4Å:- Chain A: V.125
- Chain B: I.126, R.130
2 PLIP interactions:1 interactions with chain B, 1 interactions with chain A- Salt bridges: B:R.130
- Hydrogen bonds: A:N.112
- 2 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.6: 21 residues within 4Å:- Chain A: T.142, G.166, R.167, S.168, N.170, V.171, H.198, R.199, A.219, A.220, G.221, I.222, V.240, G.241, I.242, N.243, V.278, G.279, T.282
- Ligands: 9L9.1, PO4.2
12 PLIP interactions:12 interactions with chain A- Hydrogen bonds: A:T.142, A:R.167, A:S.168, A:S.168, A:N.170, A:R.199, A:R.199, A:I.242, A:N.243
- Water bridges: A:S.168, A:S.168, A:R.199
NAD.12: 21 residues within 4Å:- Chain B: T.142, G.166, R.167, S.168, N.170, V.171, H.198, R.199, A.219, A.220, G.221, I.222, V.240, G.241, I.242, N.243, V.278, G.279, T.282
- Ligands: 9L9.7, PO4.8
12 PLIP interactions:12 interactions with chain B- Hydrogen bonds: B:T.142, B:R.167, B:S.168, B:S.168, B:N.170, B:R.199, B:R.199, B:I.242, B:N.243
- Water bridges: B:S.168, B:S.168, B:R.199
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bonagas, N. et al., Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress. Nat Cancer (2022)
- Release Date
- 2021-07-07
- Peptides
- Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 9L9: (2S)-2-[[4-[[2,4-bis(azanyl)-6-oxidanylidene-1H-pyrimidin-5-yl]carbamoylamino]phenyl]carbonylamino]pentanedioic acid(Non-covalent)
- 8 x PO4: PHOSPHATE ION(Non-functional Binders)
- 2 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bonagas, N. et al., Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress. Nat Cancer (2022)
- Release Date
- 2021-07-07
- Peptides
- Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A